Skip Navigation
Skip to contents

Endocrinol Metab : Endocrinology and Metabolism

clarivate
OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
3 "Adrenal hyperplasia, congenital"
Filter
Filter
Article type
Keywords
Publication year
Authors
Funded articles
Original Articles
Adrenal Gland
Big Data Articles (National Health Insurance Service Database)
Epidemiology and Long-Term Adverse Outcomes in Korean Patients with Congenital Adrenal Hyperplasia: A Nationwide Study
Jung Hee Kim, Sunkyu Choi, Young Ah Lee, Juneyoung Lee, Sin Gon Kim
Endocrinol Metab. 2022;37(1):138-147.   Published online February 28, 2022
DOI: https://doi.org/10.3803/EnM.2021.1328
  • 10,523 View
  • 217 Download
  • 29 Web of Science
  • 30 Crossref
AbstractAbstract PDFPubReader   ePub   
Background
Previous studies on the epidemiology and complications of congenital adrenal hyperplasia (CAH) were conducted in Western countries and in children/adolescents. We aimed to explore the epidemiology of CAH, as well as the risk of comorbidities and mortality, in a Korean nationwide case-control study.
Methods
CAH patients (n=2,840) were included between 2002 and 2017 from the National Health Insurance Service database and the Rare Intractable Disease program. CAH patients were compared, at a 1:10 ratio, with age-, sex-, and index year-matched controls (n=28,400).
Results
The point prevalence of CAH patients in Korea was 1 in 18,745 persons in 2017. The annual incidence rate declined between 2003 and 2017 from 3.25 to 0.41 per 100,000 persons. CAH patients were at elevated risk for cardiovascular disease (odds ratio [OR], 1.6; 95% confidence interval [CI], 1.4 to 1.9), stroke (OR, 1.7; 95% CI, 1.3 to 2.0), diabetes mellitus (OR, 2.8; 95% CI, 2.6 to 3.1), dyslipidemia (OR, 2.4; 95% CI, 2.2 to 2.6), and psychiatric disorders (OR, 1.5; 95% CI, 1.3 to 1.6). Fracture risk increased in CAH patients aged over 40 years (OR, 1.4; 95% CI, 1.1 to 1.7). CAH patients were at higher risk of mortality than controls (hazard ratio, 1.6; 95% CI, 1.3 to 2.0).
Conclusion
Our nationwide study showed a recent decline in the incidence of CAH and an elevated risk for cardiovascular, metabolic, skeletal, and psychiatric disorders in CAH patients. Lifelong management for comorbidity risk is a crucial component of treating CAH patients.

Citations

Citations to this article as recorded by  
  • Clinical tools for evaluating congenital adrenal hyperplasia in resource-limited hospitals: a study at a tertiary hospital in Saudi Arabia
    Daniah Alhazmi, Azzam Alabdulqader, Shahad Almeqbel, Raghad Alhuthil, Afaf Alsagheir
    Frontiers in Endocrinology.2026;[Epub]     CrossRef
  • Nationwide Big Data Studies of Endocrine Diseases Using the Korean National Health Information Database: Research Trends and Standardization of Operational Definitions
    Sun Wook Cho, Jung Hee Kim, Kyoung Jin Kim, Beom-Jun Kim, Mee Kyoung Kim, Eun Jung Rhee
    Endocrinology and Metabolism.2026; 41(1): 86.     CrossRef
  • Glucocorticoid reduction after starting crinecerfont in adult patients with classic CAH: practical perspectives
    Oksana Hamidi, Richard J Auchus, Ricardo Correa, Alice C Levine, Margaret E Wierman, Andrea L Hartzell, Vivian H Lin, Irina Bancos
    The Journal of Clinical Endocrinology & Metabolism.2026; 111(7): 1801.     CrossRef
  • Glucocorticoid reduction after starting crinecerfont in pediatric patients with classic congenital adrenal hyperplasia: practical perspectives
    Natalie J Nokoff, Patricia Y Fechner, Mimi S Kim, Ian Marshall, Deborah P Merke, Kyriakie Sarafoglou, Andrea L Hartzell, Vivian H Lin, Paul Thornton
    The Journal of Clinical Endocrinology & Metabolism.2026; 111(8): e1937.     CrossRef
  • Advances in pharmacological treatment for congenital adrenal hyperplasia
    Lara E. Graves, Henrik Falhammar
    Current Opinion in Pediatrics.2026; 38(4): 434.     CrossRef
  • Bone health in adolescents with congenital adrenal hyperplasia: exploring the interplay between glucocorticoid therapy, hormonal imbalance and puberty
    Irene Tizianel, Filippo Ceccato, Mattia Barbot
    Frontiers in Adolescent Medicine.2026;[Epub]     CrossRef
  • Pharmacotherapeutic strategies for the management of congenital adrenal hyperplasia
    Wen Huey Goai, David J. Torpy
    Expert Opinion on Pharmacotherapy.2026; 27(10): 979.     CrossRef
  • Cardiometabolic Aspects of Congenital Adrenal Hyperplasia
    Robert Krysiak, Hedi L Claahsen-van der Grinten, Nicole Reisch, Philippe Touraine, Henrik Falhammar
    Endocrine Reviews.2025; 46(1): 80.     CrossRef
  • Prevalence of Psychiatric Comorbidities in Females With Classic Congenital Adrenal Hyperplasia
    Behzad Sorouri Khorashad, Oumaima Kaabi, Melissa D Gardner, Darios Getahun, Michael Goodman, Timothy L Lash, Peter A Lee, Joshua May, Courtney McCracken, Maria Muzik, Suma Vupputuri, Rami Yacoub, David E Sandberg
    The Journal of Clinical Endocrinology & Metabolism.2025; 110(8): e2562.     CrossRef
  • Glucocorticoid therapy in classic congenital adrenal hyperplasia: traditional and new treatment paradigms
    Irina Bancos, Hyunwoo Kim, Henry K. Cheng, Mariam Rodriguez-Lee, Helen Coope, Samantha Cicero, Hannah Goldsmith, Vivian H. Lin, George S. Jeha
    Expert Review of Endocrinology & Metabolism.2025; 20(1): 33.     CrossRef
  • Clinical Manifestations and Challenges in Adolescent and Adult Females With Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
    Hedvig Engberg, Anna Nordenström, Angelica Lindén Hirschberg
    The Journal of Clinical Endocrinology & Metabolism.2025; 110(Supplement): S37.     CrossRef
  • Metabolic Syndrome Spectrum in Children with Classic Congenital Adrenal Hyperplasia—A Comprehensive Review
    Sanja Panic Zaric, Tatjana Milenkovic, Sladjana Todorovic, Katarina Mitrovic, Dimitrije Cvetkovic, Maja Cehic, Jelena Vekic, Katja Dumic, Rade Vukovic
    Metabolites.2025; 15(2): 89.     CrossRef
  • Long-term outcomes of congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a retrospective study from a tertiary care center in Saudi Arabia
    Haneen Aldalaan, Afaf Alsagheir, Nujud Alghamdi, Raghad Alhuthil, Maha Almslam, Mohamed H. Al-Hamed
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • The epidemiology of disorders of sex development
    Agnethe Berglund, Simon Chang, Marie Lind-Holst, Kirstine Stochholm, Claus Højbjerg Gravholt
    Best Practice & Research Clinical Endocrinology & Metabolism.2025; 39(4): 102002.     CrossRef
  • Causal associations between congenital adrenal hyperplasia and neuropsychiatric conditions- a Mendelian Randomization Study
    Yang Liu, Xiaokun Gang, Yuan Gao, Guixia Wang
    Endocrine.2025; 89(1): 291.     CrossRef
  • Epidemiology and clinical outcomes of clinically suspected multiple endocrine neoplasia type 1 in South Korea: a nationwide cohort study
    Kyoung Jin Kim, Min Heui Yu, Yoon-a Hwang, Shinje Moon, Namki Hong, Yumie Rhee
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • Non-classical congenital adrenal hyperplasia: current insights into clinical implications, diagnosis and treatment
    Paola Loli, Sara Menotti, Luigi di Filippo, Andrea Giustina
    Endocrine.2025; 90(1): 1.     CrossRef
  • Increased mortality in primary adrenal insufficiency: a systematic review and meta-analysis
    Konstantinos Dalakas, Francesca Allosso, Christian Basile, Ragnhildur Bergthorsdottir, Dimitrios Chantzichristos, Eva Hessman, Bright I Nwaru, Emanuele Bobbio, Daniela Pasquali, Gudmundur Johannsson, Daniela Esposito
    European Journal of Endocrinology.2025; 193(4): S53.     CrossRef
  • Exploration of the potential of genomic editing in the treatment of congenital adrenal hyperplasia
    Lara E. Graves, Sharntie Christina, Kathryn L. Mullany, Ian E. Alexander, Henrik Falhammar
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • Long‐term health consequences of congenital adrenal hyperplasia
    Riccardo Pofi, Xiaochen Ji, Nils P. Krone, Jeremy W. Tomlinson
    Clinical Endocrinology.2024; 101(4): 318.     CrossRef
  • Hyperandrogenism and Cardiometabolic Risk in Pre- and Postmenopausal Women—What Is the Evidence?
    Angelica Lindén Hirschberg
    The Journal of Clinical Endocrinology & Metabolism.2024; 109(5): 1202.     CrossRef
  • Predictors of Cardiovascular Morbidities in Adults With 21-Hydroxylase Deficiency Congenital Adrenal Hyperplasia
    Suranut Charoensri, Richard J Auchus
    The Journal of Clinical Endocrinology & Metabolism.2024; 109(3): e1133.     CrossRef
  • Case report: Development of central precocious puberty in a girl with late-diagnosed simple virilizing congenital adrenal hyperplasia complicated with Williams syndrome
    Eun Young Joo, Myung Ji Yoo, Su Jin Kim, Woori Jang, Ji-Eun Lee
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
  • Proof of concept for a superior therapeutic index of corticosterone compared with hydrocortisone in patients with congenital adrenal hyperplasia
    Catriona J Kyle, Luke D Boyle, Mark Nixon, Natalie Z M Homer, Joanna P Simpson, Alison Rutter, Lynne E Ramage, Alexandra Kelman, Ellen Marie Freel, Ruth Andrew, Brian R Walker, Roland H Stimson
    European Journal of Endocrinology.2024; 191(6): 535.     CrossRef
  • Анализ распространенности и заболеваемости надпочечниковой недостаточностью в мире
    М. Ю. Юкина, Н. Ф. Нуралиева, Е. А. Трошина
    Ateroscleroz.2023; 18(4): 426.     CrossRef
  • Big Data Research in the Field of Endocrine Diseases Using the Korean National Health Information Database
    Sun Wook Cho, Jung Hee Kim, Han Seok Choi, Hwa Young Ahn, Mee Kyoung Kim, Eun Jung Rhee
    Endocrinology and Metabolism.2023; 38(1): 10.     CrossRef
  • Long-term cardiometabolic morbidity in young adults with classic 21-hydroxylase deficiency congenital adrenal hyperplasia
    Beatrice Righi, Salma R. Ali, Jillian Bryce, Jeremy W. Tomlinson, Walter Bonfig, Federico Baronio, Eduardo C. Costa, Guilherme Guaragna-Filho, Guy T’Sjoen, Martine Cools, Renata Markosyan, Tania A. S. S. Bachega, Mirela C. Miranda, Violeta Iotova, Henrik
    Endocrine.2023; 80(3): 630.     CrossRef
  • Serum steroid profile captures metabolic phenotypes in adults with classic congenital adrenal hyperplasia
    Chang Ho Ahn, Jaeyoon Shim, Han Na Jang, Young Ah Lee, Sang-Won Lee, Man Ho Choi, Jung Hee Kim
    The Journal of Steroid Biochemistry and Molecular Biology.2023; 234: 106374.     CrossRef
  • Multiplexed Serum Steroid Profiling Reveals Metabolic Signatures of Subtypes in Congenital Adrenal Hyperplasia
    Jaeyoon Shim, Chang Ho Ahn, Seung Shin Park, Jongsung Noh, Chaelin Lee, Sang Won Lee, Jung Hee Kim, Man Ho Choi
    Journal of the Endocrine Society.2023;[Epub]     CrossRef
  • Long-Term Outcomes of Congenital Adrenal Hyperplasia
    Anna Nordenström, Svetlana Lajic, Henrik Falhammar
    Endocrinology and Metabolism.2022; 37(4): 587.     CrossRef
Close layer
Endocrine Research
Functional Identification of Compound Heterozygous Mutations in the CYP17A1 Gene Resulting in Combined 17α-Hydroxylase/17,20-Lyase Deficiency
Eun Yeong Mo, Ji-young Lee, Su Yeon Kim, Min Ji Kim, Eun Sook Kim, Seungok Lee, Je Ho Han, Sung-dae Moon
Endocrinol Metab. 2018;33(3):413-422.   Published online September 18, 2018
DOI: https://doi.org/10.3803/EnM.2018.33.3.413
  • 8,547 View
  • 76 Download
  • 4 Web of Science
  • 5 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

We previously reported a patient with congenital adrenal hyperplasia (CAH) with compound heterozygous mutations in the cytochrome P450 17A1 (CYP17A1) gene. One allele had a p.His373Leu and the other a new p.Glu383fsX36 mutation. The aim of this study was to investigate the functional properties of a new allele present in a compound heterozygote of CYP17A1.

Methods

To understand how p.His373Leu and p.Glu383fsX36 affect P450c17 enzymatic activity, wild type and mutant CYP17A1 cDNAs were cloned into flag-tagged pcDNA3 vector and introduced into human embryonic kidney cells 293T (HEK293T) cells. Protein expression levels of CYP17A1 were then analyzed. And the activities of 17α-hydroxylase and 17,20-lyase of CYP17A1 were evaluated by measuring the conversion of progesterone to 17α-hydroxyprogesterone and of 17α-hydroxypregnenolone to dehydroepiandrosterone, respectively. In addition a computer model was used to create the three-dimensional structure of the mutant CYP17A1 enzymes.

Results

Production of the p.His373Leu mutant protein was significantly lower than that of the wild type protein, and the p.Glu383fsX36 protein was hardly produced. Similarly the enzymatic activity derived from the p.His373Leu mutant vector was significantly lower than that obtained from the wild type vector, and little activity was obtained from the p.Glu383fsX36 vector. Three-dimensional modeling of the enzyme showed that p.His373 was located in region important for heme-binding and proper folding. Neither the p.His373Leu nor the p.Glu383fsX36 mutant protein formed a heme-binding structure.

Conclusion

Enzyme activity measured in both mutants disappeared completely in both 17α-hydroxylase and 17,20-lyase. This result accounts for the clinical manifestations of the patient with the compound heterozygous CYP17A1 mutations.

Citations

Citations to this article as recorded by  
  • Novel CYP17A1 variants and functional validation in a large Chinese cohort of complete 17α-hydroxylase deficiency
    Yaqing Cao, Lin Lu, Ming Li, Anli Tong, Shi Chen, Xiaoxia Zhang, Wei Zhang, Baocheng Guo, Chenjie Guo, Chuang Wang, Xi Wang, Jiangfeng Mao, Xueyan Wu, Min Nie
    The Journal of Clinical Endocrinology & Metabolism.2026;[Epub]     CrossRef
  • Clinical Characteristics and Follow-up Course of 17α-Hydroxylase/17,20-Lyase Deficiency in Korea: the OUTSPREAD Multicenter Study
    Ka Young Kim, Sung Yoon Cho, Min Jee Kim, Hwa Young Kim, Junghwan Suh, Chong Kun Cheon, Hyo-Kyoung Nam, Choong Ho Shin, Young Ah Lee, Yun Jeong Lee
    Endocrinology and Metabolism.2026;[Epub]     CrossRef
  • Clinical and endocrine correlates of genetic etiologies in severe hypospadias: Study from 34 patients
    Wen-Hua Huang, Ya-Nan Wang, Qian-Qian Tan, Wei Zeng, Xu Cui, Yong Zhou, Chao-Ming Zhou
    Journal of Pediatric Urology.2026; 22(5): 106111.     CrossRef
  • A rare case of 17α-hydroxylase/17, 20-lyase deficiency: Clinical and genetic findings and follow-up outcomes
    Li-Zhen Dai, Hong Ma, Jian-Fang Ke, Chen-Shi Lin, Yanling Huang, Yuan Tian, Danling Chen
    Women's Health.2022;[Epub]     CrossRef
  • Novel mutations of the CYP17A1 gene in four Chinese 46,XX cases with partial 17a-hydroxylase/17,20-lyase deficiency
    Yanjie Xia, Panlai Shi, Junke Xia, Huijuan Zhang, Lijun Xu, Xiangdong Kong
    Steroids.2021; 173: 108873.     CrossRef
Close layer
Case Report
Adrenal gland
Untreated Congenital Adrenal Hyperplasia with 17-α Hydroxylase/17,20-Lyase Deficiency Presenting as Massive Adrenocortical Tumor
Su Jin Lee, Je Eun Song, Sena Hwang, Ji-Yeon Lee, Hye-Sun Park, Seunghee Han, Yumie Rhee
Endocrinol Metab. 2015;30(3):408-413.   Published online August 4, 2015
DOI: https://doi.org/10.3803/EnM.2015.30.3.408
  • 9,967 View
  • 73 Download
  • 7 Web of Science
  • 10 Crossref
AbstractAbstract PDFPubReader   

Congenital adrenal hyperplasia (CAH) with 17α-hydroxylase/17,20-lyase deficiency is usually characterized by hypertension and primary amenorrhea, sexual infantilism in women, and pseudohermaphroditism in men. hypertension, and sexual infantilism in women and pseudohermaphroditism in men. In rare cases, a huge adrenal gland tumor can present as a clinical manifestation in untreated CAH. Adrenal cortical adenoma is an even more rare phenotype in CAH with 17α-hydroxylase/17,20-lyase deficiency. A 36-year-old female presented with hypertension and abdominal pain caused by a huge adrenal mass. Due to mass size and symptoms, left adrenalectomy was performed. After adrenalectomy, blood pressure remained high. Based on hormonal and genetic evaluation, the patient was diagnosed as CAH with 17α-hydroxylase/17,20-lyase deficiency. The possibility of a tumorous change in the adrenal gland due to untreated CAH should be considered. It is important that untreated CAH not be misdiagnosed as primary adrenal tumor as these conditions require different treatments. Adequate suppression of adrenocorticotropic hormone (ACTH) in CAH is also important to treat and to prevent the tumorous changes in the adrenal gland. Herein, we report a case of untreated CAH with 17α-hydroxylase/17,20-lyase deficiency presenting with large adrenal cortical adenoma and discuss the progression of adrenal gland hyperplasia due to inappropriate suppression of ACTH secretion.

Citations

Citations to this article as recorded by  
  • Indigo-functionalized BODIPY, aza-BODIPY, and BOPHY systems for CYP17A1-targeted NIR bioimaging in prostate cancer
    Naveed Khan, Rohith Ramasamy, Rajadurai Vijay Solomon
    New Journal of Chemistry.2026; 50(17): 7341.     CrossRef
  • Clinical Characteristics and Follow-up Course of 17α-Hydroxylase/17,20-Lyase Deficiency in Korea: the OUTSPREAD Multicenter Study
    Ka Young Kim, Sung Yoon Cho, Min Jee Kim, Hwa Young Kim, Junghwan Suh, Chong Kun Cheon, Hyo-Kyoung Nam, Choong Ho Shin, Young Ah Lee, Yun Jeong Lee
    Endocrinology and Metabolism.2026;[Epub]     CrossRef
  • Menarche in the third decade: congenital adrenal hyperplasia masquerading as Mayer–Rokitansky–Küster–Hauser syndrome
    Lalitha A. V. Alekya, Sravanthi Mashetty, Arun Guddeti, C V S Manasa, Aishwarya Bora, K V S Hari’Kumar
    JCEM Case Reports.2026;[Epub]     CrossRef
  • Three misdiagnoses before a final diagnosis of 17α-hydroxylase/17,20-lyase deficiency: A case report
    Jian Li, Yangguang Lu
    Medicine.2025; 104(30): e43467.     CrossRef
  • Uncommon adrenal rest tumors and massive adrenal enlargement in adult with congenital adrenal hyperplasia mimicking metastasis from pleomorphic sarcoma
    Pierluigi Mazzeo, Irene Tizianel, Francesca Galuppini, Marta Sbaraglia, Mattia Barbot
    BMC Endocrine Disorders.2024;[Epub]     CrossRef
  • Rare Types of Congenital Adrenal Hyperplasias Other Than 21-hydroxylase Deficiency
    Mehmet İsakoca, Şenay Erdeve, Semra Çetinkaya
    Journal of Clinical Research in Pediatric Endocrinology.2024;[Epub]     CrossRef
  • Congenital adrenal hyperplasia disorder due to 17 α-hydroxylase deficiency: a case report
    Yunling Tian, Lijie Hou, Shulan Xiang, Xuguang Tian, Jinhui Xu
    Gynecological Endocrinology.2023;[Epub]     CrossRef
  • Landscape of Adrenal Tumours in Patients with Congenital Adrenal Hyperplasia
    Mara Carsote, Ana-Maria Gheorghe, Claudiu Nistor, Alexandra-Ioana Trandafir, Oana-Claudia Sima, Anca-Pati Cucu, Adrian Ciuche, Eugenia Petrova, Adina Ghemigian
    Biomedicines.2023; 11(11): 3081.     CrossRef
  • 17α-Hydroxylase/17,20-Lyase Deficiency in 46,XY: Our Experience and Review of Literature
    Madhur Maheshwari, Sneha Arya, Anurag Ranjan Lila, Vijaya Sarathi, Rohit Barnabas, Khushnandan Rai, Vishwambhar Vishnu Bhandare, Saba Samad Memon, Manjiri Pramod Karlekar, Virendra Patil, Nalini S Shah, Ambarish Kunwar, Tushar Bandgar
    Journal of the Endocrine Society.2022;[Epub]     CrossRef
  • 17α-hydroxylase Deficiency Mimicking Hyperaldosteronism by Aldosterone-producing Adrenal Adenoma
    Yun Kyung Cho, Hyeseon Oh, Sun-myoung Kang, Sujong An, Jin-Young Huh, Ji-Hyang Lee, Woo Je Lee
    The Korean Journal of Medicine.2016; 91(2): 191.     CrossRef
Close layer

Endocrinol Metab : Endocrinology and Metabolism
TOP